Navigation Links
Web Resource for Interferon Research
Date:5/20/2010

New PBL InterferonSource website features knowledgebase and scientific forum dedicated to interferon and cytokine-related research tips and information.

Piscataway, NJ (PRWEB) May 20, 2010 -- For all things interferon, researchers now have a new web destination. PBL InterferonSource, the world’s leading interferon expert for life science researchers, has launched a revamped website (www.InterferonSource.com) with an all-new design, including an interferon research knowledgebase, a scientific forum, and e-commerce capability.

The new website is the product of a major initiative of the company: to serve as a highly dependable resource for interferon researchers.

The company, comprised of scientists focused solely on interferon- and cytokine-related research, has the right size and flexibility, and the right experience, knowledge, and tools, to be of tremendous value to researchers in the field. Its unique, individualized approach to clients enables the company to interact with them as scientific peers, not arms-length business customers. The new website aims to facilitate these peer-to-peer customer interactions.

PBL InterferonSource continues each year to invest in research and development, furthering its ability to serve as the knowledge resource and supplier of the best interferon-related products and services to scientists around the world. To see what’s happening in the world of interferons, please contact us at info(at)interferonsource(dot)com, or visit www.interferonsource.com.

PBL InterferonSource, a division of Pestka Biomedical Laboratories, Inc. based in Piscataway, NJ, is the world’s leading interferon expert for life science research offering interferon and related products, assay services, and consulting to the biomedical research community.

Certain statements contained herein, including statements regarding development of the Company's products, services, markets, and future demands for the Company's products and services, and other statements regarding matters that are not historical facts, are forward-looking statements. Such forward-looking statements include risks and uncertainties; consequently, actual results may differ materially from those expressed or implied thereby.

###

Read the full story at http://www.prweb.com/releases/2010/05/prweb4020704.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Gramene Announces Scholarships for Groups Underrepresented in Science to Learn How to Use Bioinformatics and Genomics Resources
2. Florida Water Resources Annual Conference Focuses on Numeric Nutrient and Other Water Issues
3. New Online Tutorials for NCBI resources BioSystems and DCODE
4. Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers
5. Emerson Resources Forges Strategic Partnership with Bio Research
6. Global Bioenergies is Setting-Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Renewable Resources
7. American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device
8. The National Center for Genome Resources Studies Childhood Diseases Using febits DNA Capture Method
9. First-Ever Egg Donor Web Portal Becomes One of The Largest Resources for Aspiring Parents in the U.S.
10. CPM Resource Center and The Shams Group Partner To Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems
11. Elsevier Health Sciences Appoints Dr. David Goldmann Editor-in-Chief of its First Consult Point of Care Resource
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Web Resource for Interferon Research 
(Date:3/27/2017)... Israel , March 27, 2017 DarioHealth ... with mobile health and big data solutions, today announced ... party insurance coverage option for U.S. consumers who want ... DarioHealth has signed strategic alliance agreements with ... verify insurance coverage benefits, and if approved, will supply ...
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research ... Stem Cell (hESC) Research - Global Strategic Business Report" report ... ... Cell (hESC) Research in US$ Million. Annual estimates and forecasts are ... are derived from primary and secondary research. The ...
(Date:3/24/2017)... March 24, 2017 Agenus Inc. (NASDAQ: AGEN), ... antibodies and cancer vaccines, today announced participation at the ...  Annual William Blair and Maidstone Life Sciences conference "Cancer ... in New York, NY . Agenus ... 29 at 9:40 am: Robert B. Stein , ...
(Date:3/23/2017)... , March 23, 2017  Northwest Biotherapeutics ... DCVax® personalized immune therapies for solid tumor cancers, ... $7.5 million financing it announced last Friday, March ... to several institutional investors securities totaling 28,843,692 shares, ... share, and 10,000,000 shares of Class C Warrants ...
Breaking Biology Technology:
(Date:2/22/2017)... Feb. 22, 2017 With the biometrics ... Research identifies four technologies that innovative and agile ... significant share in the changing competitive landscape: multifactor ... authentication.   "Companies can no longer ... security," says Dimitrios Pavlakis , Industry Analyst ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
(Date:2/14/2017)... Feb. 14, 2017  Wake Forest Baptist Medical Center ... new chief executive officer (CEO). Freischlag joins the medical ... D. McConnell , M.D., who last year announced that ... Medical Center, after leading it since 2008.   ... of Wake Forest Baptist,s academic health system, which includes ...
Breaking Biology News(10 mins):